Frontiers in Medicine (Nov 2022)

Therapeutic targeting of microglia mediated oxidative stress after neurotrauma

  • Austin N. Smith,
  • Austin N. Smith,
  • Michael Shaughness,
  • Michael Shaughness,
  • Sean Collier,
  • Sean Collier,
  • Deanna Hopkins,
  • Deanna Hopkins,
  • Kimberly R. Byrnes,
  • Kimberly R. Byrnes

DOI
https://doi.org/10.3389/fmed.2022.1034692
Journal volume & issue
Vol. 9

Abstract

Read online

Inflammation is a primary component of the central nervous system injury response. Traumatic brain and spinal cord injury are characterized by a pronounced microglial response to damage, including alterations in microglial morphology and increased production of reactive oxygen species (ROS). The acute activity of microglia may be beneficial to recovery, but continued inflammation and ROS production is deleterious to the health and function of other cells. Microglial nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), mitochondria, and changes in iron levels are three of the most common sources of ROS. All three play a significant role in post-traumatic brain and spinal cord injury ROS production and the resultant oxidative stress. This review will evaluate the current state of therapeutics used to target these avenues of microglia-mediated oxidative stress after injury and suggest avenues for future research.

Keywords